Pinnacle Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Pinnacle Wealth Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$45K	Buy	+435	New	+$41K	﹤0.01%	397

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Pinnacle Wealth Advisors's EW Position: Q2 2021 in Review

Pinnacle Wealth Advisors opened a new position in Edwards Lifesciences (EW) in Q2 2021: 435 shares worth $45K. The stake represents ﹤0.01% of the portfolio and ranks #397 among its holdings.

1,185 funds tracked by Wall St. Rank hold EW as of Q2 2021.

Pinnacle Wealth Advisors held 435 shares of Edwards Lifesciences worth $45K as of Q2 2021.
Edwards Lifesciences was a new Pinnacle Wealth Advisors position in Q2 2021.
Edwards Lifesciences made up ﹤0.01% of Pinnacle Wealth Advisors's portfolio in Q2 2021, its #397 holding.
1,185 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on Pinnacle Wealth Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.